skip to content

Cambridge Immunology Network



My research focuses at developing a complete antagonist(s) of an innate immune receptor. I take advantage of various cell-based approaches to screen a large library of compounds in order to select the most potent and non-cytotoxic ligands. Using structural biology methods, I want to confirm direct interaction between these molecules and receptor. In parallel, direct interactors active in the low concentrations will be chemically modified to improve their antagonistic parameters.


Key publications: 

β2-Adrenergic receptors in immunity and inflammation: stressing NF-κB.

Kolmus K, Tavernier J, Gerlo S.

Brain Behav Immun. 2015 Mar;45:297-310. doi: 10.1016/j.bbi.2014.10.007. Epub 2014 Oct 22. Review.


β-agonists selectively modulate proinflammatory gene expression in skeletal muscle cells via non-canonical nuclear crosstalk mechanisms.

Kolmus K, Van Troys M, Van Wesemael K, Ampe C, Haegeman G, Tavernier J, Gerlo S.

PLoS One. 2014 Mar 6;9(6):e90649. doi: 10.1371/journal.pone.0090649. eCollection 2014.


Not available for consultancy


Person keywords: 
β2-adrenergic receptors
cytokine and chemokine gene expression